News
August 28, 2008 - CoreValve said today an Australia/New Zealand-focused clinical evaluation of its proprietary percutaneous ReValving System, which features a porcine pericardium valve mounted in a self-expanding frame, was initiated last week.
August 27, 2008
Technology
The BRANSIST safire VC17 ceiling-mounted vascular package is a digital angiography system that features a 17 by 17-inch direct-conversion FPD, reportedly the largest in its class. The system is designed with not only high image quality, but also the optimal image quality for the various complex interventional procedures over the extensive field of views available.
August 27, 2008Technology
The Pathway PV Atherectomy system is designed to treat the entire spectrum of disease found in the PAD patient. The system has expandable, rotating scraping blades with aspiration for preemptive removal of both hard and soft plaque. The Pathway PV Atherectomy system reportedly provides simple set-up and easy operation to maximize effectiveness and minimize procedure time.
August 27, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC today launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disea
August 27, 2008Technology
Stereotaxis will feature its Stereotaxis magnetic navigation system, designed to allow physicians to more effectively ...
August 27, 2008Technology
The AngioJet Rheolytic Thrombectomy System included a range of specialized catheters available, allowing the physician to choose the length, diameter and clot removal power appropriate for the patient.
August 27, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
August 27, 2008 - XDx Inc. said today it received market clearance from the FDA for AlloMap Molecular Expression Testing ...
August 26, 2008Technology
ProSolv CardioVascular, a FUJIFILM company, recently released ProSolv CardioVascular 4.0, a new software release ...
August 26, 2008News
August 27, 2008 - Stereotaxis Inc. announced yesterday the FDA clearance of its magnetically tipped PowerAssert ...
August 26, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
August 27, 2008 - The Children's Hospital at Montefiore (CHAM) in the Bronx recently received approval as a pediatric heart transplant center by the New York State Department of Health. On the strength of a newly recruited pediatric cardiology team, specialists at CHAM can now treat any congenital or acquired heart abnormality in children and adolescents.
August 26, 2008Technology
Terumo Interventional Systems will feature its Runthrough NS coronary guidewire at TCT 2008. The Runthrough NS ...
August 26, 2008News
Aug. 27, 2008 — Electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) was ...
August 26, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus ...
August 26, 2008Technology
Stentys, a French-based company, will feature its bifurcated stent at TCT 2008. The patent-pending bifurcated stent is ...
August 26, 2008News
August 26, 2008 - Anthera Pharmaceuticals Inc. yesterday announced the initiation of the FRANCIS (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) clinical trial to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome (ACS) event.
August 25, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now